AIDS Research and Human Retroviruses Appoints New Co-Editors-in-Chief, Drs. R. Keith Reeves
Our very own, Dr. Reeves, will be assuming Co-Editor-in-Chief of AIDS Research and Human Retroviruses starting November of 2020. Press Release
Entries by Morgana Souza
National Academy of Medicine Elects 100 New Members
Our very own director, Dr. Dan barouch, has been elected to the National Academy of Medicine. ” For being an international leader in virology and immunology and developing novel vaccines […]
The Vaccine News That Really Matters
“Never before have there been vaccine trials that have been followed so closely from inception to onset to conduct,” Dan Barouch Read Article
Trump May Be Immune to the Coronavirus. But for How Long?
A unique treatment course may have blunted his body’s production of antibodies, scientists warn. Read Article
Covid-19 Reinfection Documented in Nevada Adds to Questions on Virus Immunity
Scientists are working at breakneck speed to develop an effective vaccine for the coronavirus. Their ultimate goal: to immunize enough of the world’s population to reach herd immunity. Read Article
Vaccine Chaos Is Looming
“Which vaccine or vaccines will prove the safest and the most effective and the most deployable? I think we don’t know yet. And that’s why having redundancy is good,” says […]
Vaccine Watch: Johnson and Johnson moves forward in vaccine trials
ABC News’ Bob Woodruff reports on Johnson and Johnson’s move to phase 3 trials for its vaccine, which unlike other vaccines is intended to be administered only once. Watch interview
Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial
After months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to […]
COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing
A COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American […]
